MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are small, non-coding RNA molecules regulating gene expression, crucial for cell development, differentiation, and function.
• Emerging evidence highlights miRNAs' role in modulating immune responses, suggesting their involvement in autoimmune diseases.
• Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis and pregnancy complications, linked to antiphospholipid antibodies (aPLs).

Purpose of the Study:

• To review the functional role of miRNAs in the immune system and autoimmune responses.
• To focus on the specific involvement of miRNAs in the pathogenesis of Antiphospholipid Syndrome (APS).
• To explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets for APS.

Main Methods:

• Literature review and synthesis of existing research on miRNAs, immune regulation, and APS.
• Analysis of studies investigating miRNA expression and function in the context of autoimmune diseases.
• Discussion of current understanding of miRNA involvement in APS pathogenesis.

Main Results:

• miRNAs significantly influence both innate and adaptive immune responses.
• Evidence indicates miRNAs are deeply implicated in the pathological mechanisms of APS.
• Specific miRNAs are associated with the development and progression of APS.

Conclusions:

• miRNAs are critical regulators of immune responses and play a significant role in autoimmune pathogenesis, including APS.
• miRNAs represent promising candidates for developing novel diagnostic biomarkers for APS.
• Targeting specific miRNAs could offer new therapeutic strategies for managing APS.